Discontinued — last reported Q3 '23
Welltower Interest Paid increased by 70.0% to $206.25M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 1.9%, from $202.38M to $206.25M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 4.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $85.35M | $119.84M | $151.61M | $123.01M | $84.02M | $157.31M | $167.33M | $148.40M | $125.58M | $148.35M | $206.26M | $149.01M | $131.27M | $110.37M | $202.38M | $129.03M | $122.98M | $121.33M | $206.25M |
| QoQ Change | — | +40.4% | +26.5% | -18.9% | -31.7% | +87.2% | +6.4% | -11.3% | -15.4% | +18.1% | +39.0% | -27.8% | -11.9% | -15.9% | +83.4% | -36.2% | -4.7% | -1.3% | +70.0% |
| YoY Change | — | — | — | — | -1.6% | +31.3% | +10.4% | +20.6% | +49.5% | -5.7% | +23.3% | +0.4% | +4.5% | -25.6% | -1.9% | -13.4% | -6.3% | +9.9% | +1.9% |
We use cookies for analytics. See our Privacy and Cookie Policy.